Kintara Therapeutics Inc. (NASDAQ:KTRA) went down by -7.60% from its latest closing price compared to the recent 1-year high of $3.35. The company’s stock price has collected -10.47% of loss in the last five trading sessions. Press Release reported on 02/17/21 that Thinking about buying stock in PAVmed, Kintara Therapeutics, Seelos Therapeutics, Novan, or Verastem?
Is It Worth Investing in Kintara Therapeutics Inc. (NASDAQ :KTRA) Right Now?
Plus, the 36-month beta value for KTRA is at 1.66. Opinions of the stock are interesting as 3 analysts out of 3 who provided ratings for Kintara Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $5.50. KTRA currently public float of 24.78M and currently shorts hold a 2.41% ratio of that float. Today, the average trading volume of KTRA was 1.09M shares.
KTRA’s Market Performance
KTRA stocks went down by -10.47% for the week, with a monthly jump of 23.53% and a quarterly performance of 46.20%, while its annual performance rate touched 261.22%. The volatility ratio for the week stands at 11.14% while the volatility levels for the past 30 days are set at 15.17% for Kintara Therapeutics Inc.. The simple moving average for the period of the last 20 days is 7.89% for KTRA stocks with a simple moving average of 77.73% for the last 200 days.
KTRA Trading at 35.75% from the 50-Day Moving Average
After a stumble in the market that brought KTRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -31.04% of loss for the given period.
Volatility was left at 15.17%, however, over the last 30 days, the volatility rate increased by 11.14%, as shares surge +26.86% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +63.83% upper at present.
During the last 5 trading sessions, KTRA fell by -10.47%, which changed the moving average for the period of 200-days by +323.78% in comparison to the 20-day moving average, which settled at $2.17. In addition, Kintara Therapeutics Inc. saw 80.47% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for KTRA
The total capital return value is set at -730.21, while invested capital returns managed to touch -818.19.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.03.